SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination

Hong-Bin Luo,Yi-Yuan Xia,Xi-Ji Shu,Zan-Chao Liu,Ye Feng,Xing-Hua Liu,Guang Yu,Gang Yin,Yan-Si Xiong,Kuan Zeng,Jun Jiang,Keqiang Ye,Xiao-Chuan Wang,Jian-Zhi Wang

DOI: https://doi.org/10.1073/pnas.1417548111

IF: 11.1

2014-11-05

Proceedings of the National Academy of Sciences

Abstract:Significance Intracellular accumulation of the abnormally modified tau is hallmark pathology of AD, but the mechanism leading to tau aggregation is not fully characterized. In the present study, we studied the effects of tau SUMOylation on its phosphorylation, ubiquitination, degradation, and aggregation. We discovered that sumoylation competes with ubiquitination in modifying tau, correlating with tau hyperphosphorylation. Identification of the posttranslational modification on tau provides the new insight into the molecular mechanism in tau aggregation.